FDA Inspection
Summa Health System IRBSumma Health System IRB – FDA Inspection, Oct 7, 2020
Record Details
This FDA Inspection record concerns Summa Health System IRB, with an inspection on October 7, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Summa Health System IRB
- Inspection Date
- October 7, 2020
- Product Type
- Drugs
View Company Profile
ID · d5efffc9-e811-43ab-90da-10c6d2d0eaef
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1130883
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 56.115(a)(6)Written procedures per 56.108(a) and (b)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Summa Health System IRB
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 26, 2026 | Not classified | Cincinnati District Office | |
| October 31, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 15, 2008 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Summa Health System IRB
- FDA Inspection 1319414 - 2026-05-26
- FDA Inspection 902022 - 2014-10-31
- FDA Inspection 552055 - 2008-12-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.